Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

Danaher Corporation

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Medical - Diagnostics & ResearchSector: Healthcare

Fair Value Summary

Current Price$224.70
5Y Range96.10 – 153.26
5Y Selected124.68
(-) Safety Margin68.74%
5Y Buy Price$38.97
Upside (to Buy Price)-82.65%
10Y Range104.59 – 160.89
10Y Selected132.74
(-) Safety Margin68.74%
10Y Buy Price$41.50
Upside (to Buy Price)-81.53%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.0176
Revenue R2 (10Y)0.6683
Net Income R2 (5Y)0.0137
Net Income R2 (10Y)0.4480
EBITDA R2 (5Y)0.0121
EBITDA R2 (10Y)0.6660
FCF R2 (5Y)0.0626
FCF R2 (10Y)0.6124
Safety Score0.3126

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth3.58%3.63%3.67%3.72%3.77%3.81%3.86%3.91%3.95%4.00%
Revenue24,729.5725,626.2926,567.5027,555.6928,593.5229,683.8130,829.5432,033.9033,300.2834,632.29
EBITDA8,051.278,343.228,649.658,971.389,309.279,664.2410,037.2610,429.3710,841.6711,275.33
D&A-1,947.61-2,018.23-2,092.35-2,170.18-2,251.92-2,337.78-2,428.02-2,522.87-2,622.60-2,727.51
EBIT6,103.676,324.996,557.306,801.207,057.367,326.467,609.247,906.508,219.068,547.82
Pro forma Taxes-1,018.03-1,054.94-1,093.69-1,134.37-1,177.09-1,221.97-1,269.14-1,318.72-1,370.85-1,425.69
NOPAT5,085.645,270.055,463.615,666.835,880.266,104.486,340.106,587.786,848.217,122.14
Capital Expenditures-1,044.88-1,082.77-1,122.54-1,164.29-1,208.14-1,254.21-1,302.62-1,353.51-1,407.02-1,463.30
NWC Investment-75.85-79.59-83.54-87.71-92.11-96.77-101.69-106.89-112.40-118.22
(+) D&A1,947.612,018.232,092.352,170.182,251.922,337.782,428.022,522.872,622.602,727.51
Free Cash Flow5,912.526,125.926,349.896,585.026,831.937,091.297,363.817,650.257,951.408,268.13
Diluted Shares Outstanding722,700,000.00722,700,000.00722,700,000.00722,700,000.00722,700,000.00722,700,000.00722,700,000.00722,700,000.00722,700,000.00722,700,000.00

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/26/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/13/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.461.462.463.464.465.466.467.468.46
Valuation Date1/16/26

Base Case Projected Flows

WACC: 9.10%Terminal Growth: 2.33%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.880.810.740.680.620.570.520.48
PV UFCF5,861.265,885.405,591.835,315.305,054.724,809.084,577.444,358.924,152.703,958.01
Raw: 103,364.10
73,217.56
Raw: 125,093.24
57,331.78

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value100,926.05106,896.43
(-) Net Debt15,394.5015,394.50
Equity Value85,531.5591,501.93
(/) Shares Out722.70722.70
Fair Value$118.35$126.61
(-) Safety Margin68.74%68.74%
Buy Price$37.00$39.58
Current Price$224.70$224.70
Upside (to Buy Price)-83.54%-82.39%

Conservative Projected Flows

WACC: 10.10%Terminal Growth: 1.83%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.870.790.720.650.590.540.490.44
PV UFCF5,855.915,860.755,517.835,197.324,897.634,617.314,354.994,109.423,879.443,663.98
Raw: 84,188.76
57,518.50
Raw: 101,886.88
43,030.32

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value84,847.9490,984.89
(-) Net Debt15,394.5015,394.50
Equity Value69,453.4475,590.39
(/) Shares Out722.70722.70
Fair Value$96.10$104.59
(-) Safety Margin68.74%68.74%
Buy Price$30.04$32.70
Current Price$224.70$224.70
Upside (to Buy Price)-86.63%-85.45%

Aggressive Projected Flows

WACC: 8.10%Terminal Growth: 2.83%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.890.830.760.710.650.600.560.52
PV UFCF5,866.665,910.385,667.515,437.085,218.365,010.704,813.474,626.084,447.994,278.68
Raw: 133,467.94
98,052.58
Raw: 161,525.50
80,396.08

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value126,152.57131,672.98
(-) Net Debt15,394.5015,394.50
Equity Value110,758.07116,278.48
(/) Shares Out722.70722.70
Fair Value$153.26$160.89
(-) Safety Margin68.74%68.74%
Buy Price$47.91$50.30
Current Price$224.70$224.70
Upside (to Buy Price)-78.68%-77.62%

Reverse DCF: Market Implied Growth

Current Price$224.70
WACC Used9.1%
IMPLIED REVENUE GROWTH153.54%
Metric2027202820292030203120322033203420352036
Implied Revenue61,529.10156,000.90395,524.731,002,813.562,542,533.896,446,341.4216,344,056.5641,438,727.39105,063,765.62266,378,712.38
Constant Implied Growth153.54%153.54%153.54%153.54%153.54%153.54%153.54%153.54%153.54%153.54%
Implied Free Cash Flow6.1515.6039.55100.28254.25644.631,634.414,143.8710,506.3826,637.87
Discount Factor0.930.810.740.680.620.570.520.480.440.40
Present Value of Implied FCF5.7312.5929.2668.01158.05367.30853.581,983.704,610.0610,713.61

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$136.04-1.71%$61.01-55.15%
20182018-12-31$91.416.69%$85.93-6.00%
20172017-12-31$82.2813.22%$95.9616.63%
20162016-12-31$69.0011.55%$88.1427.75%
20152015-12-31$62.404.62%$69.4411.28%
20142014-12-31$57.583.80%$82.6943.60%
20132013-12-31$51.86-0.64%$63.4822.41%
20122012-12-31$37.55-2.33%$52.5239.88%
20112011-12-31$31.60-4.35%$34.8810.37%
20102010-12-31$31.69-2.07%$37.3817.96%
20092009-12-31$25.268.21%$52.01105.88%
20082008-12-31$19.0211.74%$61.23221.93%
20072007-12-31$29.478.73%$46.6558.30%
20062006-12-31$24.336.07%$41.3970.14%
20052005-12-31$18.745.05%$31.6969.09%
20042004-12-31$19.288.42%$30.9260.40%
20032003-12-31$15.4114.72%$35.55130.71%
20022002-12-31$11.0317.73%$33.06199.70%
20012001-12-31$10.1318.35%$28.88185.10%
20002000-12-31$11.4817.30%$22.0091.60%
19991999-12-31$8.1013.10%$12.0749.07%
19981998-12-31$9.129.91%$-12.49-236.93%
19971997-12-31$5.309.18%$8.1453.51%
19961996-12-31$3.9214.56%$8.27111.09%
19951995-12-31$2.6717.84%$7.15167.90%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$130.38
Median
$126.22
10th Percentile
$104.35
90th Percentile
$162.90

Fair Value Distribution

$82.90 - $92.09
16
$92.09 - $101.27
56
$101.27 - $110.46
125
$110.46 - $119.65
163
$119.65 - $128.84
190
$128.84 - $138.03
138
$138.03 - $147.22
106
$147.22 - $156.40
66
$156.40 - $165.59
55
$165.59 - $174.78
32
$174.78 - $183.97
24
$183.97 - $193.16
10
$193.16 - $202.35
11
$202.35 - $211.53
1
$211.53 - $220.72
1
$220.72 - $229.91
4
$229.91 - $239.10
1
$239.10 - $248.29
0
$248.29 - $257.47
0
$257.47 - $266.66
1